| Angiogenesis and chronic inflammation: cause or consequence? C Costa, J Incio, R Soares Angiogenesis 10, 149-166, 2007 | 536 | 2007 |
| Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy J Incio, H Liu, P Suboj, SM Chin, IX Chen, M Pinter, MR Ng, HT Nia, ... Cancer discovery 6 (8), 852-869, 2016 | 367 | 2016 |
| Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy J Incio, H Liu, P Suboj, SM Chin, IX Chen, M Pinter, MR Ng, HT Nia, ... Cancer discovery 6 (8), 852-869, 2016 | 367 | 2016 |
| Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy J Incio, H Liu, P Suboj, SM Chin, IX Chen, M Pinter, MR Ng, HT Nia, ... Cancer discovery 6 (8), 852-869, 2016 | 367 | 2016 |
| Solid stress and elastic energy as measures of tumour mechanopathology HT Nia, H Liu, G Seano, M Datta, D Jones, N Rahbari, J Incio, ... Nature biomedical engineering 1 (1), 0004, 2016 | 358 | 2016 |
| BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors AC Faber, RB Corcoran, H Ebi, LV Sequist, BA Waltman, E Chung, J Incio, ... Cancer discovery 1 (4), 352-365, 2011 | 331 | 2011 |
| Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases NN Rahbari, D Kedrin, J Incio, H Liu, WW Ho, HT Nia, CM Edrich, K Jung, ... Science translational medicine 8 (360), 360ra135-360ra135, 2016 | 215 | 2016 |
| Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable C Mavian, SK Pond, S Marini, BR Magalis, AM Vandamme, S Dellicour, ... Proceedings of the National Academy of Sciences 117 (23), 12522-12523, 2020 | 185* | 2020 |
| Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2 J Incio, JA Ligibel, DT McManus, P Suboj, K Jung, K Kawaguchi, M Pinter, ... Science translational medicine 10 (432), eaag0945, 2018 | 184 | 2018 |
| Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases DP Kodack, E Chung, H Yamashita, J Incio, AMMJ Duyverman, Y Song, ... Proceedings of the National Academy of Sciences 109 (45), E3119-E3127, 2012 | 166 | 2012 |
| Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy K Jung, T Heishi, OF Khan, PS Kowalski, J Incio, NN Rahbari, E Chung, ... The Journal of clinical investigation 127 (8), 3039-3051, 2017 | 148 | 2017 |
| PlGF/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity J Incio, J Tam, NN Rahbari, P Suboj, DT McManus, SM Chin, TD Vardam, ... Clinical Cancer Research 22 (12), 2993-3004, 2016 | 139 | 2016 |
| Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages J Incio, P Suboj, SM Chin, T Vardam-Kaur, H Liu, T Hato, S Babykutty, ... PloS one 10 (12), e0141392, 2015 | 137 | 2015 |
| Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer K Jung, T Heishi, J Incio, Y Huang, EY Beech, M Pinter, WW Ho, ... Proceedings of the National Academy of Sciences 114 (39), 10455-10460, 2017 | 106 | 2017 |
| Use of angiotensin system inhibitors is associated with immune activation and longer survival in nonmetastatic pancreatic ductal adenocarcinoma H Liu, K Naxerova, M Pinter, J Incio, H Lee, K Shigeta, WW Ho, JA Crain, ... Clinical Cancer Research 23 (19), 5959-5969, 2017 | 83 | 2017 |
| Obesity and cancer: an angiogenic and inflammatory link D Fukumura, J Incio, RC Shankaraiah, RK Jain Microcirculation 23 (3), 191-206, 2016 | 66 | 2016 |
| Evidence for the effects of xanthohumol in disrupting angiogenic, but not stable vessels R Negrão, J Incio, R Lopes, I Azevedo, R Soares International journal of biomedical science: IJBS 3 (4), 279, 2007 | 23 | 2007 |
| Tumor angiogenesis regulators RR Gonzalez-Perez, BR Rueda CRC Press, 2013 | 20 | 2013 |
| A phase II study of preoperative (preop) bevacizumab (bev) followed by dose-dense (dd) doxorubicin (A)/cyclophosphamide (C)/paclitaxel (T) in combination with bev in HER2 … SM Tolaney, DG Duda, Y Boucher, S Goel, J Martin, M Ancukiewicz, ... Journal of Clinical Oncology 30 (15_suppl), 1026-1026, 2012 | 13 | 2012 |
| BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. Cancer Discov. 2011; 1: 352–65. doi: 10.1158/2159-8290 AC Faber, RB Corcoran, H Ebi, LV Sequist, BA Waltman, E Chung, J Incio, ... CD-11-0106.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 7 | |
